SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals, Inc. (Nasdaq:LGND), launched a fully redesigned public Web site at www.ligand.com. The site is designed around our new business model and provides increased functionality and interactivity. “Our new Web site brings to life Ligand’s core foundation, which is our science. Ligand has gone through significant changes this year, and we have expanded the content and redesigned the functionality of the Web site to reflect our new business strategy and opportunities,” said John L. Higgins, President and CEO. “Our goal is to make this useful for investors, prospective corporate partners and future employees.”
